Science Explorer Back to mapMap
Institution · Rigshospitalet

Most cited papers from Rigshospitalet

What are the most cited papers from Rigshospitalet?

The most cited paper from Rigshospitalet is "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials" (Julian P. T. Higgins, Doug G. Altman, Peter Christian Gøtzsche et al., 2011), with 34,881 citations. Next come "The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology" (16,252) and "Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines" (11,535).

Showing 50 of 56 papers. Every paper with more than 2,463 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The Cochrane Collaboration's tool for assessing risk of bias in randomised trials Julian P. T. Higgins, Doug G. Altman, Peter Christian Gøtzsche et al. · BMJ Open access 18 Oct 2011 34,881
2 The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology N.K. Aaronson, Sam Hjelmeland Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute 3 Mar 1993 16,252
3 Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry et al. · Journal of Extracellular Vesicles Open access382 authors 23 Nov 2018 11,535
4 CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials David Moher, Sally Hopewell, Kenneth F. Schulz et al. · BMJ Open access 23 Mar 2010 9,147
5 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman et al. · PLoS Medicine Open access 10 Oct 2007 8,626
6 Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Alan J. Thompson et al. · The Lancet Neurology Open access 21 Dec 2017 8,265
7 Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction John J.V. McMurray et al. · New England Journal of Medicine Open access 19 Sep 2019 7,135
8 SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials A.-W. Chan, Jennifer Tetzlaff, Peter Christian Gøtzsche et al. · BMJ Open access 9 Jan 2013 7,135
9 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Andrew Rhodes et al. · Intensive Care Medicine Open access 18 Jan 2017 6,868
10 European Position Paper on Rhinosinusitis and Nasal Polyps 2020 W.J. Fokkens et al. · Rhinology Journal Open access148 authors Feb 2020 5,610
11 Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Laura Evans et al. · Intensive Care Medicine Open access 2 Oct 2021 5,314
12 Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms Ilkka Kuorinka, Björn G. Jonsson, Åsa Kilbom et al. · Applied Ergonomics Sep 1987 5,161
13 Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Martine J Piccart et al. · New England Journal of Medicine Open access 20 Oct 2005 5,138
14 Allergic Rhinitis and its Impact on Asthma (ARIA) 2008* Jean Bousquet et al. · Allergy Open access 7 Mar 2008 4,764
15 Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention Pim A.L. Tonino, Bernard De Bruyne, Nico H.J. Pijls et al. · New England Journal of Medicine Open access 14 Jan 2009 4,279
16 Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization Veronika Whitesell Skrivankova, Rebecca Claire Richmond, Benjamin A. R. Woolf et al. · JAMA Open access 26 Oct 2021 4,188
17 Persistent postsurgical pain: risk factors and prevention Henrik Kehlet, Troels Staehelin Jensen, Clifford J. Woolf · The Lancet May 2006 4,102
18 Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer Sarah C. Darby, Marianne Ewertz, Paul McGale et al. · New England Journal of Medicine Open access 13 Mar 2013 4,034
19 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
20 Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases Bente Klarlund Pedersen, Bengt Saltin · Scandinavian Journal of Medicine and Science in Sports Open access 25 Nov 2015 3,588
21 Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations Robert H. Dworkin et al. · Journal of Pain Open access 13 Dec 2007 3,496
22 Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes Peter Gæde, Henrik Lund‐Andersen, Hans‐Henrik Parving et al. · New England Journal of Medicine Open access 6 Feb 2008 3,489
23 Ageing as a risk factor for neurodegenerative disease Yujun Hou, Xiuli Dan, Mansi Babbar et al. · Nature Reviews Neurology Review 9 Sep 2019 3,412
24 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
25 Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression eQTLGen et al. · Nature Genetics Open access218 authors 26 Apr 2018 3,347
26 Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Ole Thastrup, Peter J. Cullen, Bjørn K. Drøbak et al. · Proceedings of the National Academy of Sciences Open access Apr 1990 3,301
27 Antibiotic resistance of bacterial biofilms Niels Høiby, Thomas Bjarnsholt, Michael Givskov et al. · International Journal of Antimicrobial Agents 11 Feb 2010 3,283
28 ESPEN Guidelines for Nutrition Screening 2002 Jens Kondrup · Clinical Nutrition 22 Jul 2003 3,169
29 The anti-inflammatory effect of exercise Anne Marie Winther Petersen, Bente Klarlund Pedersen · Journal of Applied Physiology 16 Mar 2005 3,096
30 Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials Jens Kondrup · Clinical Nutrition 25 Mar 2003 3,078
31 Enzalutamide in Metastatic Prostate Cancer before Chemotherapy Tomasz M. Beer et al. · New England Journal of Medicine Open access Jun 2014 3,076
32 Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients Michael J. Reardon et al. · New England Journal of Medicine Open access 17 Mar 2017 3,033
33 Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults Nadja Larsen, Finn Kvist Vogensen, Frans W.J. van den Berg et al. · PLoS ONE Open access 4 Feb 2010 3,014
34 SignalP 6.0 predicts all five types of signal peptides using protein language models Felix Teufel, José Juan Almagro Armenteros, Alexander Rosenberg Johansen et al. · Nature Biotechnology Open access 3 Jan 2022 2,998
35 Some new, simple and efficient stereological methods and their use in pathological research and diagnosis H. J. G. Gundersen, Thomas Fichtner Bendtsen, Lise Korbo et al. · Apmis 1988 2,964
36 Muscles, exercise and obesity: skeletal muscle as a secretory organ Bente Klarlund Pedersen, Mark Anthony Febbraio · Nature Reviews Endocrinology Review 3 Apr 2012 2,921
37 When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts Janus Christian Jakobsen, Christian Nyfeldt Gluud, Jørn Wetterslev et al. · BMC Medical Research Methodology Open access Dec 2017 2,864
38 An atlas of active enhancers across human cell types and tissues Robin Andersson et al. · Nature Open access Mar 2014 2,854
39 Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children Alexander Edward Dela Cruz Drilon et al. · New England Journal of Medicine Open access 21 Feb 2018 2,827
40 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update Josef S Smolen et al. · Annals of the Rheumatic Diseases Open access 22 Jan 2020 2,807
41 Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest Niklas Nielsen et al. · New England Journal of Medicine Open access 17 Nov 2013 2,799
42 Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society Børge Grønne Nordestgaard et al. · European Heart Journal Open access 15 Aug 2013 2,797
43 Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease Bernard De Bruyne et al. · New England Journal of Medicine Open access 28 Aug 2012 2,784
44 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman et al. · Epidemiology Open access Nov 2007 2,777
45 Evidence for decreasing quality of semen during past 50 years. Elisabeth Carlsen, Aleksander Giwercman, Niels Keiding et al. · BMJ Open access 12 Sep 1992 2,775
46 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Martin Aringer et al. · Arthritis & Rheumatology Open access 6 Aug 2019 2,644
47 New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics Open access1,266 authors Apr 2022 2,608
48 Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy Marie Overgaard, Per Syrak Hansen, Jens Overgaard et al. · New England Journal of Medicine 2 Oct 1997 2,591
49 Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study Lesley J. Wood, Matthias Egger, Lise Lotte Gluud et al. · BMJ Open access 3 Mar 2008 2,582
50 The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis H.J.G. Gundersen, Peter Valdemar Bagger, Thomas Fichtner Bendtsen et al. · Apmis Jul 1988 2,506

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.